$ABBV bad news after bad newsHas had multiple bad news on trials
I see it bouncing off the major TL and pointed out the potential scenarios
I will buy LEAPs on it once a higher low is set.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.87 USD
4.82 B USD
54.32 B USD
1.77 B
About AbbVie Inc.
Sector
CEO
Robert A. Michael
Headquarters
North Chicago
Website
Founded
2011
FIGI
BBG0025Y4RY4
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
ABBV gap fill tradeABBV is my fav next to LLY.
Scooped up some ABBV for a gap fill bounce above.
Target 1 - 175
Target 2 - 190
Let's revisit it once it crosses 175
Leaning Bullish on ABBV after Strong Reaction to EarningsABBV had a solid reaction to earnings. The tight consolidation over the last few days supports a bullish momentum holding up. Volume declining over the last few days (when price has been declining) typically means a healthy consolidation before a continued rise.
While the price may/may not continue
ABBVIE broke below the 1D MA50. Confirmed sell opportunity.AbbVie Inc. (ABBV) has been trading within a Channel Up pattern since the November 09 2023 Low. Having made a Higher High on September 04 and been rejected at the top of the Channel Up, the price broke and closed aggressively below its 1D MA50 (blue trend-line) three days ago. That is a confirmed te
ABBV appeared the break pointABBV completed the flat pattern after the event of break out
From the pivot to 5%, you can add more position and establish the stop loss at the low price of the previous day break out
ABBV ShortABBV has climbed 21% since early July. The Sellers here might be trying to get a reversal.
Pivot 197.54
Any price below pivot is a short. Weekly close under this price is a good sign for continuation.
ABBV - I guess Not late for the Party !! ABBV - 135 level would’ve been ideal entry for long but it’s not too late to join the party.
It's just cleared 155 level.
Next, gap fill above upto 165.
After that, Target 1 : 175
ABBV ZonesAll rectangles are potential zones of influence for support/resistance pressure. Same applies to the 2 curves.
1st, I don't know if the red will prove to offer more resistance to the price as initially suspected, or failing and triggering a penetration.
2nd, even if it does prove to be a resistanc
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ABBV is featured.
Frequently Asked Questions
The current price of ABBV is 180.00 USD — it has increased by 1.60% in the past 24 hours. Watch AbbVie Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange AbbVie Inc. stocks are traded under the ticker ABBV.
ABBV stock has risen by 3.91% compared to the previous week, the month change is a 2.32% rise, over the last year AbbVie Inc. has showed a 17.42% increase.
We've gathered analysts' opinions on AbbVie Inc. future price: according to them, ABBV price has a max estimate of 240.00 USD and a min estimate of 165.00 USD. Watch ABBV chart and read a more detailed AbbVie Inc. stock forecast: see what analysts think of AbbVie Inc. and suggest that you do with its stocks.
ABBV reached its all-time high on Oct 31, 2024 with the price of 207.32 USD, and its all-time low was 32.51 USD and was reached on Dec 17, 2012. View more price dynamics on ABBV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ABBV stock is 1.31% volatile and has beta coefficient of 0.18. Track AbbVie Inc. stock price on the chart and check out the list of the most volatile stocks — is AbbVie Inc. there?
Today AbbVie Inc. has the market capitalization of 315.24 B, it has increased by 1.72% over the last week.
Yes, you can track AbbVie Inc. financials in yearly and quarterly reports right on TradingView.
AbbVie Inc. is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
ABBV earnings for the last quarter are 3.00 USD per share, whereas the estimation was 2.92 USD resulting in a 2.74% surprise. The estimated earnings for the next quarter are 2.98 USD per share. See more details about AbbVie Inc. earnings.
AbbVie Inc. revenue for the last quarter amounts to 14.46 B USD, despite the estimated figure of 14.28 B USD. In the next quarter, revenue is expected to reach 14.82 B USD.
ABBV net income for the last quarter is 1.55 B USD, while the quarter before that showed 1.36 B USD of net income which accounts for 14.04% change. Track more AbbVie Inc. financial stats to get the full picture.
Yes, ABBV dividends are paid quarterly. The last dividend per share was 1.55 USD. As of today, Dividend Yield (TTM)% is 3.48%. Tracking AbbVie Inc. dividends might help you take more informed decisions.
AbbVie Inc. dividend yield was 3.87% in 2023, and payout ratio reached 220.33%. The year before the numbers were 3.53% and 86.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 50.00 K employees. See our rating of the largest employees — is AbbVie Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AbbVie Inc. EBITDA is 25.32 B USD, and current EBITDA margin is 49.30%. See more stats in AbbVie Inc. financial statements.
Like other stocks, ABBV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AbbVie Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AbbVie Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AbbVie Inc. stock shows the buy signal. See more of AbbVie Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.